Transient receptor potential calcium channels like TRPC3 and TRPC6 have been found to be elevated in breast, ovarian, liver and stomach tumors, and silencing of calcium channel expression has been shown to reduce proliferation in a breast cancer cell line and reduce tumor formation in a xenograft mouse model [13, 14]. This evidence concerns the gene TRPC6 and breast cancer.